Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults with Atopic Dermatitis

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Stay informed about new Trial Results Summaries with our email notification service

Country	Location
Australia	ACT, Australia, 02606
Australia	Liverpool, Australia, 2170
Australia	Woolloongabba, Australia, 04102
Canada, British Columbia	Surrey, British Columbia, Canada, V3R 6A7
Canada, ON	Barrie, ON, Canada, L4M 6L2
Canada, QC	Quebec, QC, Canada, G1V 4X7
Germany	Berlin, Germany, 10117
Germany	Frankfurt/Main, Germany, 60590
Germany	Gera, Germany, 07548
Germany	Hannover, Germany, 30625
Germany	Leipzig, Germany, 04103
Germany	München, Germany, 80337
Germany	Münster, Germany, 48149
Germany	Tübingen, Germany, 72076
Germany	Witten, Germany, 42287
Hungary	Debrecen, Hungary, 4032
Hungary	Kaposvár, Hungary, 7400
Hungary	Miskolc, Hungary, 3529
Hungary	Pécs, Hungary, 7632
Hungary	Szeged, Hungary, 6720
Hungary	Szombathely, Hungary, 9700
New Zealand	Tauranga, New Zealand, 3143
New Zealand	Wellington, New Zealand, 6021
United States of America, Fl	North Miami Beach, Fl, United States of America, 33162
United States of America, FL	Tampa, FL, United States of America, 33624
United States of America, IL	Arlington Hts, IL, United States of America, 60005
United States of America, IN	Indianapolis, IN, United States of America, 46256
United States of America, Indiana	Carmel, Indiana, United States of America, 46032
United States of America, NC	Charlotte, NC, United States of America, 28277
United States of America, NJ	Berlin, NJ, United States of America, 08009
United States of America, OR	Portland, OR, United States of America, 97239
United States of America, TX	Pflugerville, TX, United States of America, 78660